PubMed Health⌕ Search

Biomedical subjects

F R Levin

Publications and source records attributed to F R Levin.

28 records · Page 2Linked to original sources

Cardiovascular effects of cocaine in humans: laboratory studies.

Studies in which healthy, carefully screened, experienced cocaine users receive cocaine under controlled laboratory conditions, although often overlooked by the medical community, are an excellent source of data on the cardiovascular effects of cocaine. Cocaine is generally self-administered in repeated-dose 'binges', and studies simulating this pattern provide interesting cardiovascular information, such as the selective development of acute tolerance or the unique effects of some drug combinations. Studies with intranasal, intravenous, and smoked cocaine all show that under conditions in which subjects are allowed to take cocaine repeatedly, heart rate generally returns to near baseline levels between doses despite gradually increasing cocaine blood levels. Blood pressure either shows the same pattern, or gradual increases with repeated dosing. Analyses of cardiovascular activity as a function of cocaine plasma level indicate the rapid development of acute (i.e., within session) tolerance to cocaine. Cocaine self-administration often occurs in the presence of behavioral stressors, or in combination with other drugs of abuse or cocaine abuse treatment medications. Performance of a behaviorally-demanding task increases heart rate and blood pressure. When cocaine is taken prior to task performance larger increases in heart rate are observed than with either drug or task alone. An unexpected cardiovascular interaction was observed in subjects who inhaled cocaine and drank ethanol-containing beverages. This combination resulted in heart rate increases that were significantly larger than observed with either drug alone. Combinations of i.v. cocaine and smoked marijuana also increased heart rate above levels seen with either drug alone. A single intravenous dose of cocaine and morphine in combination, however, produced cardiovascular effects similar to those produced by cocaine alone. The effects of these drug combinations on blood pressure were often equal to the effect of one drug alone. Since cocaine is frequently taken in combination with potential treatment drugs, these interactions can be assessed under controlled settings prior to large-scale treatment studies. For instance, maintenance on the antidepressant desipramine increased baseline heart rate and diastolic pressure. Cocaine administration engendered increases in heart rate and blood pressure above the desipramine-elevated baselines. Clearly, drug interactions can have unexpected cardiovascular effects, and laboratory studies provide a controlled setting for understanding and studying these interactions.

Alcohol Drinking↗

Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence.

This study was conducted to determine the effectiveness of carbamazepine (CBZ) for treatment of cocaine dependence. Sixty-two (CBZ = 28, placebo = 34) cocaine-dependent (DSM-III-R criteria) volunteers consented to be treated for eight weeks with standardized outpatient individual counseling twice a week plus double-blind CBZ or inactive placebo. During the 8-week trial, both groups showed increased number of urine samples negative for cocaine, significantly (P < 0.01) decreased self-reported cocaine use (money spent and grams used), and decreased Beck Depression Inventory and Symptom Check List-90-Revised (SCL-90-R) total scores. However, there were no significant differences between CBZ and placebo. This study does not support the effectiveness of CBZ for outpatient treatment of cocaine dependence.

Adult↗

Effects of single and multiple intravenous cocaine injections in humans maintained on methadone.

The effects of i.v. cocaine were examined in individuals maintained on methadone. Sixteen adult methadone-maintained i.v. cocaine users, residing on a clinical research unit, participated in eight laboratory sessions under each of two conditions: cocaine 1 hr after daily methadone and cocaine 22 hr after daily methadone. The conditions were separated by an outpatient period of 3 to 5 weeks. During the first five sessions, the cardiovascular and subjective effects of single i.v. cocaine doses (0, 8, 16, 32 or 48 mg/70 kg) were determined. During the last three sessions, the effects of i.v. cocaine (0, 8 or 32 mg/70 kg) administered 4 times per session at 14-min intervals were determined. Single and repeated doses of cocaine produced dose-dependent increases in cardiovascular effects (e.g., diastolic pressure and heart rate), subjective effects (e.g., ratings of "High," or "Stimulated") and ratings of cocaine dose (e.g., "Quality," or "Liking"), regardless of methadone dose or the timing of cocaine administration. Increases in blood pressure after single cocaine doses were greater when cocaine was given 1 hr after methadone. Subjects maintained on higher methadone doses (> 60 mg) reported larger cocaine effects after single doses on several measures including ratings of Liking and Stimulated. Finally, the opiate symptom scores after cocaine administration were 100% larger than those observed previously after cocaine administration to opiate-experienced, but not dependent, individuals. These data suggest that any improvement in cocaine abuse observed in methadone-maintained individuals is not related to a blocking of the subjective effects of cocaine, and that higher methadone doses could have a negative impact on cocaine abuse in some individuals.

Adult↗

Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction.

Many pharmacologic regimens have been recommended as supplemental treatment strategies for cocaine abuse. Using the technique of meta-analysis, we compared and combined the data from six studies to examine the efficacy of desipramine as an adjunctive treatment approach for cocaine addiction. These studies were randomized, placebo-controlled clinical trials of desipramine and involved a total of 200 cocaine-addicted patients. We found that desipramine is no better than placebo in retaining patients in treatment. However, while patients are in treatment, desipramine is helpful in promoting abstinence (p less than 0.001). There were several compromises made to use meta-analysis for these studies. These included comparing patient populations with different psychiatric and substance use diagnoses, comparing studies that used varying amounts of psychotherapy, and comparing studies that defined certain outcome variables in diverse ways. There are other limitations in the use of meta-analysis that were not specific to the studies we compared. These include such issues as statistical bias and publication bias. The purpose of this paper is to suggest the use of meta-analysis as one way to help the clinician evaluate the literature and to point out the areas of difficulty when assessing the literature.

Cocaine↗

Trauma and trauma-related disorders for women on methadone: prevalence and treatment considerations.

There is a growing recognition of the strong association between psychoactive substance abuse and violence. Repeated exposure to violent trauma is particularly salient for women. Moreover, violent trauma may play a role in the etiologies of depression, substance abuse, and trauma-related disorders, such as posttraumatic stress disorder (PTSD). For the female methadone patient, an untreated trauma-related disorder can be a hidden factor that hinders treatment response and leads to treatment complications, such as depression, polysubstance abuse, or treatment drop out. This article reviews the prevalence of trauma and violence for women on methadone, comparing low-income, inner-city female drug abusers with males in methadone treatment on childhood and adulthood exposure to violent trauma and PTSD. Because women are in a minority in methadone maintenance treatment programs, standard treatment approaches have generally not focused on their particular issues and needs. Two alternative models are presented for group treatment of trauma and trauma-related disorders in female methadone patients; potential benefits of each in reducing symptomatology and improving interpersonal functioning are examined. Modification of standard approaches and the typical barriers to engagement in treatment for this special population are also addressed.

Child↗

Dissociative identity disorder and substance abuse: the forgotten relationship.

The treatment and research of dissociative disorders, particularly dissociative identity disorder (DID), are hampered by professional skepticism and diagnostic uncertainties. Almost always associated with severe and sustained childhood trauma, its chief manifestations are at least two distinct and separate identities which have an independent manner of existing in the world. It is also associated with a high degree of psychiatric comorbidity. Among the most frequent diagnoses found in patients with DID are substance use and dependence. For a variety of reasons there has been little dialogue among the disciplines that study patients with trauma and those that study and treat substance abuse. Clinicians dealing with a primarily substance-abusing population are likely to encounter but not recognize these patients. The authors present several representative cases illustrative of features of patients with DID. The epidemiology, phenomenology and presentation of DID, as well as its relation to posttraumatic stress disorder are discussed. Little systematic investigation exists on the treatment of DID in general, and substance abuse in DID in particular. The authors draw upon the existing literature, and their experience to discuss treatment strategies aimed at treating patients with both diagnoses. Ignoring either diagnosis is likely to be detrimental to patients; both disorders and their coexistence need to be addressed.

Adult↗

Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment.

Attention-deficit hyperactivity disorder (ADHD) and substance-use disorders are related to each other in a variety of ways. Although within the child-psychiatry literature earlier investigations were inconsistent regarding such a link, recent prospective studies that followed hyperactive children and normal controls into adulthood have found that hyperactive adults with a history of ADHD are more likely than controls to have substance-use disorders. The substance-abuse literature is less consistent regarding the potential association between ADHD and substance abuse. However, recent studies suggest that persons with a substance-use disorder, and particularly those with a cocaine-use disorder, may be more likely than the general population to have a childhood history of ADHD. Some of the inconsistency regarding this association is due to differences in diagnostic criteria, type of assessments used, and reliability of information obtained. Each of the potential relationships that may exist between ADHD and substance abuse has treatment implications for the clinician. Pharmacological as well as nonpharmacological approaches deserve further investigation. Because pharmacotherapy is a central component in the treatment of childhood ADHD, clinicians designing a strategy to treat both a substance-use disorder and ADHD need to consider pharmacological interventions. At present, the literature on pharmacological treatment for childhood ADHD is extensive and that for adult ADHD is growing; information regarding the treatment of cocaine abuse and concomitant ADHD symptoms remains limited.

Adolescent↗